SLC16A3 (NM_001042423) Human 3' UTR Clone

CAT#: SC206956

3`UTR clone of solute carrier family 16 member 3 (monocarboxylic acid transporter 4) (SLC16A3) transcript variant 3 for miRNA target validation

Specifications

Product Data

• Vector: pMirTarget
• Species: Human
• Transfection Reporter: RFP
• Assay Reporter: Luciferase
• E. coli Selection: Kanamycin (25 ug/mL)
• Mammalian Cell Selection: Neomycin
• Symbol: SLC16A3
• Synonyms: MCT-3; MCT-4; MCT 3; MCT3; MCT 4; MCT4
• ACCN: NM_001042423
• Insert Size: 556
• Sequence Data:
  Insert Sequence

  >SC206956 3'UTR clone of NM_001042423
  The sequence shown below is from the reference sequence of NM_001042423. The complete sequence of this clone may contain minor differences, such as SNPs. Red=Cloning site Blue=Stop Codon
  
  
  CAATTGGCAGAGCTCAGAATTCAAGCGATCGC
  
  AAAACGGGGAGGTGGTTCACACCCCGGAAACAAGTGTCTGAGTGGCTGGGCGGGGCCGGCAGGCACAGGG
  AGGAGGTACAGAAGCCGGCAACGCTTGCTATTTATTTTACAAACTGGACTGGCTCAGGCAGGGCCACGGC
  TGGGCTCCAGCTGCCGGCCCAGCGGATCGTCGCCCGATCAGTGTTTTGAGGGGGAAGGTGGCGGGGTGGG
  AACCGTGTCATTCCAGAGTGGATCTGCGGTGAAGCCAAGCCGCAAGGTTACAAGGCATCCTCACCAGGGG
  CCCCGCCTGCTGCTCCCAGGTGGCCTGCGGCCACTGCTATGCTCAAGGACCTGGAAACCCATGCTTCGAG
  ACAACGTGACTTTAATGGGAGGGTGGGTGGGCCGCAGACAGGCTGGCAGGGCAGGTGCTGCGTGGGGCCC
  TCTCCAGCCCGTCCTACCCTGGGCTCACATGGGGCCTGTGCCCACCCCTCTTGAGTGTCTTGGGGACAGC
  TCTTTCCACCCCTGGAAGATGGAAATAAACCTGCGTGTGGGTGGAGTGTTAGGACCAACGGTTTCC
  
  ACGCGTAAGCGGCCGCGGCATCTAGATTCGAAGAAAATGACCG
• Restriction Sites: SgfI-MluI
• OTI Disclaimer: Our molecular clone sequence data has been matched to the sequence identifier above as a point of reference. Note that the complete sequence of this clone is largely the same as the reference sequence but may contain minor differences , e.g., single nucleotide polymorphisms (SNPs).

Reference Data

• RefSeq: NM_001042423.1
• Summary: Lactic acid and pyruvate transport across plasma membranes is catalyzed by members of the proton-linked monocarboxylate transporter (MCT) family, which has been designated solute carrier family-16. Each MCT appears to have slightly different substrate and inhibitor specificities and transport kinetics, which are related to the metabolic requirements of the tissues in which it is found. The MCTs, which include MCT1 (SLC16A1; MIM 600682) and MCT2 (SLC16A7; MIM 603654), are characterized by 12 predicted transmembrane domains (Price et al., 1998 [PubMed 9425115]). [supplied by OMIM, Mar 2008]
• Locus ID: 9123